Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1401

1

2seventy bio, Inc. 2seventy bio Reports Decreased Assets, Improved Losses, and Focus on Abecma Development

Via official filing (AI summary) | 11 days ago | 0 comments

1402

1

Biohaven Ltd. Biohaven Reports Significant Operating Expenses and Net Losses in Q3 2024, Completes Acquisition and Raises Capital

Via official filing (AI summary) | 11 days ago | 0 comments

1403

1

ACACIA RESEARCH CORP Acacia Research Corporation Reports 131% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1404

1

Perspective Therapeutics, Inc. Perspective Therapeutics Reports Significant Financial Growth and Cash Flow Improvement

Via official filing (AI summary) | 11 days ago | 0 comments

1405

1

Nuwellis, Inc. Nuwellis Reports Improved Financials, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1406

1

Rhinebeck Bancorp, Inc. Rhinebeck Bancorp Reports Net Loss of $8.1M in Q3 2024, Net Loss of $6.0M for Nine Months

Via official filing (AI summary) | 11 days ago | 0 comments

1407

1

Ares Acquisition Corp II Ares Acquisition Corporation II Reports Net Income Growth, Doubts on Going Concern

Via official filing (AI summary) | 11 days ago | 0 comments

1408

1

NORTHWEST BIOTHERAPEUTICS INC Northwest Biotherapeutics Reports Significant Revenue Growth, But Continues to Face Financial Challenges

Via official filing (AI summary) | 11 days ago | 0 comments

1409

1

iANTHUS CAPITAL HOLDINGS, INC. iAnthus Capital Holdings Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1410

1

Electromed, Inc. Electromed, Inc. Reports 19% Revenue Growth and Improved Profitability in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1411

1

PSYCHEMEDICS CORP Psychemedics Reports 9% Revenue Decline, Reduces Operating Expenses, and Plans Reverse/Forward Stock Split

Via official filing (AI summary) | 11 days ago | 0 comments

1412

1

TERAWULF INC. TeraWulf Reports Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1413

1

Pioneer Bancorp, Inc./MD Pioneer Bancorp Reports Strong Financial Growth and Strategic Progress in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1414

1

PowerFleet, Inc. PowerFleet Reports 124.9% Revenue Growth in Q3 2024, Net Loss Despite MiX Telematics Acquisition

Via official filing (AI summary) | 11 days ago | 0 comments

1415

1

LISATA THERAPEUTICS, INC. Lisata Therapeutics Reports Third Quarter and Nine Months Financial Results, Focuses on Clinical Development Efforts

Via official filing (AI summary) | 11 days ago | 0 comments

1416

1

Rumble Inc. Rumble Inc. Reports Revenue Growth, Narrowing Losses in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1417

1

FIBROGEN INC FibroGen Reports 15% Revenue Growth, Improved Net Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1418

1

CXApp Inc. CXApp Inc. Reports Mixed Financial Results, Widening Net Loss Despite Revenue Growth

Via official filing (AI summary) | 11 days ago | 0 comments

1419

1

MARINUS PHARMACEUTICALS, INC. Marinus Pharmaceuticals Reports Revenue Growth, Net Loss, and Significant Financial Changes in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1420

1

DYADIC INTERNATIONAL INC Dyadic International Reports Significant Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1421

1

Atara Biotherapeutics, Inc. Atara Biotherapeutics Reports Significant Revenue Growth, Net Loss Reduction in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1422

1

Lionsgate Studios Corp. Lionsgate Studios Reports Mixed Financial Results, Net Loss Amid Revenue Growth

Via official filing (AI summary) | 11 days ago | 0 comments

1423

1

MARIN SOFTWARE INC Marin Software Reports Mixed Q3 Results, Declining Revenues but Improved Gross Profit Margins

Via official filing (AI summary) | 11 days ago | 0 comments

1424

1

Artiva Biotherapeutics, Inc. Artiva Biotherapeutics Reports Significant Financial Developments, Including Increased Assets and Net Loss

Via official filing (AI summary) | 11 days ago | 0 comments

1425

1

COLOMBIER ACQUISITION CORP. II Colombier Acquisition Corp. II Reports Financial Performance Following IPO, Net Income Turnaround

Via official filing (AI summary) | 11 days ago | 0 comments